APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Validation Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pharmaceutical Validation Services Market Analysis and Forecast 2026-2032

17 January 2026190 pages

Choose your research edition.

Industry ResearchPharmaceutical Validation Services Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Validation Services Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Validation Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Validation Services Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Validation Services Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Pharmaceutical Validation Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Pharmaceutical Validation Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pharmaceutical Validation Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pharmaceutical Validation Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pharmaceutical Validation Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Pharmaceutical Validation Services include Arbor Group, ATS Global, Catalent, CRS Pharma Solutions, Eurofins Scientific, Körber Pharma, Merck Millipore, MTS (Meissner Technical Services) and Navitas pharma READY, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Pharmaceutical Validation Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pharmaceutical Validation Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Pharmaceutical Validation Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharmaceutical Validation Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pharmaceutical Validation Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pharmaceutical Validation Services revenue, projected growth trends, production technology, application and end-user industry.

Pharmaceutical Validation Services Segment by Company

Arbor Group

ATS Global

Catalent

CRS Pharma Solutions

Eurofins Scientific

Körber Pharma

Merck Millipore

MTS (Meissner Technical Services)

Navitas pharma READY

PharmOut

SGS

Sigma-Aldrich

SL Controls

Transcat

Pharmaceutical Validation Services Segment by Type

Pharmaceutical Cleaning Validation Services

Pharmaceutical Equipment Validation Services

Others

Pharmaceutical Validation Services Segment by Application

Pharmaceutical Companies

Biotechnological Companies

Academic and Research Institutes

Pharmaceutical Validation Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Validation Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Validation Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Validation Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Pharmaceutical Validation Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pharmaceutical Validation Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Validation Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmaceutical Validation Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Pharmaceutical Cleaning Validation Services Major Player Table 3. Pharmaceutical Equipment Validation Services Major Player Table 4. Others Major Player Table 5. Global Pharmaceutical Validation Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Pharmaceutical Companies Major Player Table 7. Biotechnological Companies Major Player Table 8. Academic and Research Institutes Major Player Table 9. Pharmaceutical Validation Services Industry Trends Table 10. Pharmaceutical Validation Services Industry Drivers Table 11. Pharmaceutical Validation Services Industry Opportunities and Challenges Table 12. Pharmaceutical Validation Services Industry Restraints Table 13. Global Pharmaceutical Validation Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Pharmaceutical Validation Services Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Pharmaceutical Validation Services Market Share by Region (2021-2026) Table 16. Global Pharmaceutical Validation Services Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Pharmaceutical Validation Services Market Share by Region (2027-2032) Table 18. Global Pharmaceutical Validation Services Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Pharmaceutical Validation Services Revenue Market Share by Players (2021-2026) Table 20. Global Pharmaceutical Validation Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Pharmaceutical Validation Services Key Players Headquarters & Area Served Table 22. Global Pharmaceutical Validation Services Players, Product Type & Application Table 23. Global Pharmaceutical Validation Services Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Pharmaceutical Validation Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Pharmaceutical Validation Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pharmaceutical Validation Services Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Pharmaceutical Validation Services Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Pharmaceutical Validation Services Revenue Market Share by Type (2021-2026) Table 30. Global Pharmaceutical Validation Services Revenue Market Share by Type (2027-2032) Table 31. Global Pharmaceutical Validation Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pharmaceutical Validation Services Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Pharmaceutical Validation Services Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Pharmaceutical Validation Services Revenue Market Share by Application (2021-2026) Table 35. Global Pharmaceutical Validation Services Revenue Market Share by Application (2027-2032) Table 36. Arbor Group Company Information Table 37. Arbor Group Business Overview Table 38. Arbor Group Pharmaceutical Validation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Arbor Group Pharmaceutical Validation Services Product Portfolio Table 40. Arbor Group Recent Development Table 41. ATS Global Company Information Table 42. ATS Global Business Overview Table 43. ATS Global Pharmaceutical Validation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. ATS Global Pharmaceutical Validation Services Product Portfolio Table 45. ATS Global Recent Development Table 46. Catalent Company Information Table 47. Catalent Business Overview Table 48. Catalent Pharmaceutical Validation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Catalent Pharmaceutical Validation Services Product Portfolio Table 50. Catalent Recent Development Table 51. CRS Pharma Solutions Company Information Table 52. CRS Pharma Solutions Business Overview Table 53. CRS Pharma Solutions Pharmaceutical Validation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. CRS Pharma Solutions Pharmaceutical Validation Services Product Portfolio Table 55. CRS Pharma Solutions Recent Development Table 56. Eurofins Scientific Company Information Table 57. Eurofins Scientific Business Overview Table 58. Eurofins Scientific Pharmaceutical Validation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Eurofins Scientific Pharmaceutical Validation Services Product Portfolio Table 60. Eurofins Scientific Recent Development Table 61. Körber Pharma Company Information Table 62. Körber Pharma Business Overview Table 63. Körber Pharma Pharmaceutical Validation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Körber Pharma Pharmaceutical Validation Services Product Portfolio Table 65. Körber Pharma Recent Development Table 66. Merck Millipore Company Information Table 67. Merck Millipore Business Overview Table 68. Merck Millipore Pharmaceutical Validation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Merck Millipore Pharmaceutical Validation Services Product Portfolio Table 70. Merck Millipore Recent Development Table 71. MTS (Meissner Technical Services) Company Information Table 72. MTS (Meissner Technical Services) Business Overview Table 73. MTS (Meissner Technical Services) Pharmaceutical Validation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. MTS (Meissner Technical Services) Pharmaceutical Validation Services Product Portfolio Table 75. MTS (Meissner Technical Services) Recent Development Table 76. Navitas pharma READY Company Information Table 77. Navitas pharma READY Business Overview Table 78. Navitas pharma READY Pharmaceutical Validation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Navitas pharma READY Pharmaceutical Validation Services Product Portfolio Table 80. Navitas pharma READY Recent Development Table 81. PharmOut Company Information Table 82. PharmOut Business Overview Table 83. PharmOut Pharmaceutical Validation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. PharmOut Pharmaceutical Validation Services Product Portfolio Table 85. PharmOut Recent Development Table 86. SGS Company Information Table 87. SGS Business Overview Table 88. SGS Pharmaceutical Validation Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. SGS Pharmaceutical Validation Services Product Portfolio Table 90. SGS Recent Development Table 91. Sigma-Aldrich Company Information Table 92. Sigma-Aldrich Business Overview Table 93. Sigma-Aldrich Pharmaceutical Validation Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Sigma-Aldrich Pharmaceutical Validation Services Product Portfolio Table 95. Sigma-Aldrich Recent Development Table 96. SL Controls Company Information Table 97. SL Controls Business Overview Table 98. SL Controls Pharmaceutical Validation Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. SL Controls Pharmaceutical Validation Services Product Portfolio Table 100. SL Controls Recent Development Table 101. Transcat Company Information Table 102. Transcat Business Overview Table 103. Transcat Pharmaceutical Validation Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Transcat Pharmaceutical Validation Services Product Portfolio Table 105. Transcat Recent Development Table 106. North America Pharmaceutical Validation Services Revenue by Type (2021-2026) & (US$ Million) Table 107. North America Pharmaceutical Validation Services Revenue by Type (2027-2032) & (US$ Million) Table 108. North America Pharmaceutical Validation Services Revenue by Application (2021-2026) & (US$ Million) Table 109. North America Pharmaceutical Validation Services Revenue by Application (2027-2032) & (US$ Million) Table 110. North America Pharmaceutical Validation Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. North America Pharmaceutical Validation Services Revenue by Country (2021-2026) & (US$ Million) Table 112. North America Pharmaceutical Validation Services Revenue by Country (US$ Million) & (2027-2032) Table 113. Europe Pharmaceutical Validation Services Revenue by Type (2021-2026) & (US$ Million) Table 114. Europe Pharmaceutical Validation Services Revenue by Type (2027-2032) & (US$ Million) Table 115. Europe Pharmaceutical Validation Services Revenue by Application (2021-2026) & (US$ Million) Table 116. Europe Pharmaceutical Validation Services Revenue by Application (2027-2032) & (US$ Million) Table 117. Europe Pharmaceutical Validation Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Europe Pharmaceutical Validation Services Revenue by Country (2021-2026) & (US$ Million) Table 119. Europe Pharmaceutical Validation Services Revenue by Country (US$ Million) & (2027-2032) Table 120. China Pharmaceutical Validation Services Revenue by Type (2021-2026) & (US$ Million) Table 121. China Pharmaceutical Validation Services Revenue by Type (2027-2032) & (US$ Million) Table 122. China Pharmaceutical Validation Services Revenue by Application (2021-2026) & (US$ Million) Table 123. China Pharmaceutical Validation Services Revenue by Application (2027-2032) & (US$ Million) Table 124. Asia Pharmaceutical Validation Services Revenue by Type (2021-2026) & (US$ Million) Table 125. Asia Pharmaceutical Validation Services Revenue by Type (2027-2032) & (US$ Million) Table 126. Asia Pharmaceutical Validation Services Revenue by Application (2021-2026) & (US$ Million) Table 127. Asia Pharmaceutical Validation Services Revenue by Application (2027-2032) & (US$ Million) Table 128. Asia Pharmaceutical Validation Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Asia Pharmaceutical Validation Services Revenue by Region (US$ Million) & (2021-2026) Table 130. Asia Pharmaceutical Validation Services Revenue by Region (US$ Million) & (2027-2032) Table 131. SAMEA Pharmaceutical Validation Services Revenue by Type (2021-2026) & (US$ Million) Table 132. SAMEA Pharmaceutical Validation Services Revenue by Type (2027-2032) & (US$ Million) Table 133. SAMEA Pharmaceutical Validation Services Revenue by Application (2021-2026) & (US$ Million) Table 134. SAMEA Pharmaceutical Validation Services Revenue by Application (2027-2032) & (US$ Million) Table 135. SAMEA Pharmaceutical Validation Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. SAMEA Pharmaceutical Validation Services Revenue by Country (2021-2026) & (US$ Million) Table 137. SAMEA Pharmaceutical Validation Services Revenue by Country (US$ Million) & (2027-2032) Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Pharmaceutical Validation Services Image Figure 2. Global Pharmaceutical Validation Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Validation Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Pharmaceutical Cleaning Validation Services Image Figure 5. Pharmaceutical Equipment Validation Services Image Figure 6. Others Image Figure 7. Global Pharmaceutical Validation Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Pharmaceutical Validation Services Market Size Share 2021 VS 2025 VS 2032 Figure 9. Pharmaceutical Companies Image Figure 10. Biotechnological Companies Image Figure 11. Academic and Research Institutes Image Figure 12. Global Pharmaceutical Validation Services Market Size (US$ Million) & (2021-2032) Figure 13. Global Pharmaceutical Validation Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Pharmaceutical Validation Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Pharmaceutical Validation Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Pharmaceutical Validation Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Pharmaceutical Validation Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Pharmaceutical Validation Services Revenue Market Share by Type (2021-2032) Figure 20. Global Pharmaceutical Validation Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Pharmaceutical Validation Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Pharmaceutical Validation Services Revenue Market Share by Application (2021-2032) Figure 23. North America Pharmaceutical Validation Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Pharmaceutical Validation Services Revenue Share by Type (2021-2032) Figure 25. North America Pharmaceutical Validation Services Revenue Share by Application (2021-2032) Figure 26. North America Pharmaceutical Validation Services Revenue Share by Country (2021-2032) Figure 27. United States Pharmaceutical Validation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Pharmaceutical Validation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Pharmaceutical Validation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Pharmaceutical Validation Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Pharmaceutical Validation Services Revenue Share by Type (2021-2032) Figure 32. Europe Pharmaceutical Validation Services Revenue Share by Application (2021-2032) Figure 33. Europe Pharmaceutical Validation Services Revenue Share by Country (2021-2032) Figure 34. Germany Pharmaceutical Validation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Pharmaceutical Validation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Pharmaceutical Validation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Pharmaceutical Validation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Pharmaceutical Validation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Pharmaceutical Validation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Pharmaceutical Validation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Pharmaceutical Validation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Pharmaceutical Validation Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Pharmaceutical Validation Services Revenue Share by Type (2021-2032) Figure 44. China Pharmaceutical Validation Services Revenue Share by Application (2021-2032) Figure 45. Asia Pharmaceutical Validation Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Pharmaceutical Validation Services Revenue Share by Type (2021-2032) Figure 47. Asia Pharmaceutical Validation Services Revenue Share by Application (2021-2032) Figure 48. Asia Pharmaceutical Validation Services Revenue Share by Region (2021-2032) Figure 49. Japan Pharmaceutical Validation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Pharmaceutical Validation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Pharmaceutical Validation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Pharmaceutical Validation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Pharmaceutical Validation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Pharmaceutical Validation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Pharmaceutical Validation Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Pharmaceutical Validation Services Revenue Share by Type (2021-2032) Figure 57. SAMEA Pharmaceutical Validation Services Revenue Share by Application (2021-2032) Figure 58. SAMEA Pharmaceutical Validation Services Revenue Share by Country (2021-2032) Figure 59. Brazil Pharmaceutical Validation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Pharmaceutical Validation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Pharmaceutical Validation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Pharmaceutical Validation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Pharmaceutical Validation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Pharmaceutical Validation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Pharmaceutical Validation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Pharmaceutical Validation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Pharmaceutical Validation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Pharmaceutical Validation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Pharmaceutical Validation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Pharmaceutical Cleaning Validation Services
  • Pharmaceutical Equipment Validation Services
  • Others
Applications
  • Pharmaceutical Companies
  • Biotechnological Companies
  • Academic and Research Institutes
Companies covered
  • Arbor Group
  • ATS Global
  • Catalent
  • CRS Pharma Solutions
  • Eurofins Scientific
  • Körber Pharma
  • Merck Millipore
  • MTS (Meissner Technical Services)
  • Navitas pharma READY
  • PharmOut
  • SGS
  • Sigma-Aldrich
  • SL Controls
  • Transcat

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pharmaceutical Validation Services Market by Type
  3. 1.2.1 Global Pharmaceutical Validation Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Pharmaceutical Cleaning Validation Services
  5. 1.2.3 Pharmaceutical Equipment Validation Services
  6. 1.2.4 Others
  7. 1.3 Pharmaceutical Validation Services Market by Application
  8. 1.3.1 Global Pharmaceutical Validation Services Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Pharmaceutical Companies
  10. 1.3.3 Biotechnological Companies
  11. 1.3.4 Academic and Research Institutes
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Pharmaceutical Validation Services Market Dynamics
  1. 2.1 Pharmaceutical Validation Services Industry Trends
  2. 2.2 Pharmaceutical Validation Services Industry Drivers
  3. 2.3 Pharmaceutical Validation Services Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Validation Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Pharmaceutical Validation Services Market Perspective (2021-2032)
  2. 3.2 Global Pharmaceutical Validation Services Growth Trends by Region
  3. 3.2.1 Global Pharmaceutical Validation Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pharmaceutical Validation Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Pharmaceutical Validation Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Pharmaceutical Validation Services Revenue by Players
  2. 4.1.1 Global Pharmaceutical Validation Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Pharmaceutical Validation Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Pharmaceutical Validation Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pharmaceutical Validation Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Pharmaceutical Validation Services Key Players Headquarters & Area Served
  7. 4.4 Global Pharmaceutical Validation Services Players, Product Type & Application
  8. 4.5 Global Pharmaceutical Validation Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Pharmaceutical Validation Services Market CR5 and HHI
  11. 4.6.3 2025 Pharmaceutical Validation Services Tier 1, Tier 2, and Tier 3
5 Pharmaceutical Validation Services Market Size by Type
  1. 5.1 Global Pharmaceutical Validation Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharmaceutical Validation Services Revenue by Type (2021-2032)
  3. 5.3 Global Pharmaceutical Validation Services Revenue Market Share by Type (2021-2032)
6 Pharmaceutical Validation Services Market Size by Application
  1. 6.1 Global Pharmaceutical Validation Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Pharmaceutical Validation Services Revenue by Application (2021-2032)
  3. 6.3 Global Pharmaceutical Validation Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Arbor Group
  2. 7.1.1 Arbor Group Company Information
  3. 7.1.2 Arbor Group Business Overview
  4. 7.1.3 Arbor Group Pharmaceutical Validation Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Arbor Group Pharmaceutical Validation Services Product Portfolio
  6. 7.1.5 Arbor Group Recent Developments
  7. 7.2 ATS Global
  8. 7.2.1 ATS Global Company Information
  9. 7.2.2 ATS Global Business Overview
  10. 7.2.3 ATS Global Pharmaceutical Validation Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 ATS Global Pharmaceutical Validation Services Product Portfolio
  12. 7.2.5 ATS Global Recent Developments
  13. 7.3 Catalent
  14. 7.3.1 Catalent Company Information
  15. 7.3.2 Catalent Business Overview
  16. 7.3.3 Catalent Pharmaceutical Validation Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Catalent Pharmaceutical Validation Services Product Portfolio
  18. 7.3.5 Catalent Recent Developments
  19. 7.4 CRS Pharma Solutions
  20. 7.4.1 CRS Pharma Solutions Company Information
  21. 7.4.2 CRS Pharma Solutions Business Overview
  22. 7.4.3 CRS Pharma Solutions Pharmaceutical Validation Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 CRS Pharma Solutions Pharmaceutical Validation Services Product Portfolio
  24. 7.4.5 CRS Pharma Solutions Recent Developments
  25. 7.5 Eurofins Scientific
  26. 7.5.1 Eurofins Scientific Company Information
  27. 7.5.2 Eurofins Scientific Business Overview
  28. 7.5.3 Eurofins Scientific Pharmaceutical Validation Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Eurofins Scientific Pharmaceutical Validation Services Product Portfolio
  30. 7.5.5 Eurofins Scientific Recent Developments
  31. 7.6 Körber Pharma
  32. 7.6.1 Körber Pharma Company Information
  33. 7.6.2 Körber Pharma Business Overview
  34. 7.6.3 Körber Pharma Pharmaceutical Validation Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Körber Pharma Pharmaceutical Validation Services Product Portfolio
  36. 7.6.5 Körber Pharma Recent Developments
  37. 7.7 Merck Millipore
  38. 7.7.1 Merck Millipore Company Information
  39. 7.7.2 Merck Millipore Business Overview
  40. 7.7.3 Merck Millipore Pharmaceutical Validation Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Merck Millipore Pharmaceutical Validation Services Product Portfolio
  42. 7.7.5 Merck Millipore Recent Developments
  43. 7.8 MTS (Meissner Technical Services)
  44. 7.8.1 MTS (Meissner Technical Services) Company Information
  45. 7.8.2 MTS (Meissner Technical Services) Business Overview
  46. 7.8.3 MTS (Meissner Technical Services) Pharmaceutical Validation Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 MTS (Meissner Technical Services) Pharmaceutical Validation Services Product Portfolio
  48. 7.8.5 MTS (Meissner Technical Services) Recent Developments
  49. 7.9 Navitas pharma READY
  50. 7.9.1 Navitas pharma READY Company Information
  51. 7.9.2 Navitas pharma READY Business Overview
  52. 7.9.3 Navitas pharma READY Pharmaceutical Validation Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Navitas pharma READY Pharmaceutical Validation Services Product Portfolio
  54. 7.9.5 Navitas pharma READY Recent Developments
  55. 7.10 PharmOut
  56. 7.10.1 PharmOut Company Information
  57. 7.10.2 PharmOut Business Overview
  58. 7.10.3 PharmOut Pharmaceutical Validation Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 PharmOut Pharmaceutical Validation Services Product Portfolio
  60. 7.10.5 PharmOut Recent Developments
  61. 7.11 SGS
  62. 7.11.1 SGS Company Information
  63. 7.11.2 SGS Business Overview
  64. 7.11.3 SGS Pharmaceutical Validation Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 SGS Pharmaceutical Validation Services Product Portfolio
  66. 7.11.5 SGS Recent Developments
  67. 7.12 Sigma-Aldrich
  68. 7.12.1 Sigma-Aldrich Company Information
  69. 7.12.2 Sigma-Aldrich Business Overview
  70. 7.12.3 Sigma-Aldrich Pharmaceutical Validation Services Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Sigma-Aldrich Pharmaceutical Validation Services Product Portfolio
  72. 7.12.5 Sigma-Aldrich Recent Developments
  73. 7.13 SL Controls
  74. 7.13.1 SL Controls Company Information
  75. 7.13.2 SL Controls Business Overview
  76. 7.13.3 SL Controls Pharmaceutical Validation Services Revenue and Gross Margin (2021-2026)
  77. 7.13.4 SL Controls Pharmaceutical Validation Services Product Portfolio
  78. 7.13.5 SL Controls Recent Developments
  79. 7.14 Transcat
  80. 7.14.1 Transcat Company Information
  81. 7.14.2 Transcat Business Overview
  82. 7.14.3 Transcat Pharmaceutical Validation Services Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Transcat Pharmaceutical Validation Services Product Portfolio
  84. 7.14.5 Transcat Recent Developments
8 North America
  1. 8.1 North America Pharmaceutical Validation Services Revenue (2021-2032)
  2. 8.2 North America Pharmaceutical Validation Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Pharmaceutical Validation Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Pharmaceutical Validation Services Revenue by Type (2027-2032)
  5. 8.3 North America Pharmaceutical Validation Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Pharmaceutical Validation Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Pharmaceutical Validation Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Pharmaceutical Validation Services Revenue by Application (2027-2032)
  9. 8.5 North America Pharmaceutical Validation Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Pharmaceutical Validation Services Revenue by Country
  11. 8.6.1 North America Pharmaceutical Validation Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Pharmaceutical Validation Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Pharmaceutical Validation Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Pharmaceutical Validation Services Revenue (2021-2032)
  2. 9.2 Europe Pharmaceutical Validation Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Pharmaceutical Validation Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Pharmaceutical Validation Services Revenue by Type (2027-2032)
  5. 9.3 Europe Pharmaceutical Validation Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Pharmaceutical Validation Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Pharmaceutical Validation Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Pharmaceutical Validation Services Revenue by Application (2027-2032)
  9. 9.5 Europe Pharmaceutical Validation Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Pharmaceutical Validation Services Revenue by Country
  11. 9.6.1 Europe Pharmaceutical Validation Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Pharmaceutical Validation Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Pharmaceutical Validation Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Pharmaceutical Validation Services Revenue (2021-2032)
  2. 10.2 China Pharmaceutical Validation Services Revenue by Type (2021-2032)
  3. 10.2.1 China Pharmaceutical Validation Services Revenue by Type (2021-2026)
  4. 10.2.2 China Pharmaceutical Validation Services Revenue by Type (2027-2032)
  5. 10.3 China Pharmaceutical Validation Services Revenue Share by Type (2021-2032)
  6. 10.4 China Pharmaceutical Validation Services Revenue by Application (2021-2032)
  7. 10.4.1 China Pharmaceutical Validation Services Revenue by Application (2021-2026)
  8. 10.4.2 China Pharmaceutical Validation Services Revenue by Application (2027-2032)
  9. 10.5 China Pharmaceutical Validation Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pharmaceutical Validation Services Revenue (2021-2032)
  2. 11.2 Asia Pharmaceutical Validation Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Pharmaceutical Validation Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Pharmaceutical Validation Services Revenue by Type (2027-2032)
  5. 11.3 Asia Pharmaceutical Validation Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Pharmaceutical Validation Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Pharmaceutical Validation Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Pharmaceutical Validation Services Revenue by Application (2027-2032)
  9. 11.5 Asia Pharmaceutical Validation Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Pharmaceutical Validation Services Revenue by Country
  11. 11.6.1 Asia Pharmaceutical Validation Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Pharmaceutical Validation Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Pharmaceutical Validation Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pharmaceutical Validation Services Revenue (2021-2032)
  2. 12.2 SAMEA Pharmaceutical Validation Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Pharmaceutical Validation Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Pharmaceutical Validation Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Pharmaceutical Validation Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Pharmaceutical Validation Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Pharmaceutical Validation Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Pharmaceutical Validation Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Pharmaceutical Validation Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Pharmaceutical Validation Services Revenue by Country
  11. 12.6.1 SAMEA Pharmaceutical Validation Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Pharmaceutical Validation Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Pharmaceutical Validation Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst